Real-World Evidence Shows Clinicians Appropriately Use the Prognostic 40-Gene Expression Profile (40-GEP) Test for High-Risk Cutaneous Squamous Cell Carcinoma (cSCC) Patients-Reference-Cited by-同舟云学术

Real-World Evidence Shows Clinicians Appropriately Use the Prognostic 40-Gene Expression Profile (40-GEP) Test for High-Risk Cutaneous Squamous Cell Carcinoma (cSCC) Patients

Published:2022-09-15 Issue:10 Volume:40 Page:911-922
ISSN:0735-7907
Container-title:Cancer Investigation
language:en
Short-container-title:Cancer Investigation

Author:

Hooper Perry B.¹,Farberg Aaron S.²,Fitzgerald Alison L.³,Siegel Jennifer J.³,Rackley Briana B.³,Prasai Anesh³,Kurley Sarah J.³,Goldberg Matthew S.³,Litchman Graham H.⁴^ORCID

Affiliation:

1. Department of Dermatology, Indiana University School of Medicine, Indianapolis, IN, USA

2. Baylor Scott & White Health System, Dallas, TX, USA

3. Castle Biosciences, Inc, Friendswood, TX, USA

4. St. John’s Episcopal Hospital, Far Rockaway, NY, USA

Funder

Castle Biosciences, Inc

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/07357907.2022.2116454

Reference51 articles.

1. Skin cancer foundation: our new approach to a challenging skin cancer statistic. The skin cancer foundation; 2021. [cited 2021 Jun 14]. Available from: https://www.skincancer.org/blog/our-new-approach-to-a-challenging-skin-cancer-statistic/.

2. Cutaneous Squamous Cell Carcinoma

3. Skin cancer foundation: skin cancer facts & statistics. The skin cancer foundation, 2021. [cited 2021 Jun 14]. Available from: https://www.skincancer.org/skin-cancer-information/skin-cancer-facts/.

4. Cutaneous squamous cell carcinoma staging may influence management in users: A survey study

5. Risk Factors for Cutaneous Squamous Cell Carcinoma Recurrence, Metastasis, and Disease-Specific Death

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Prognostic Value and Clinical Utility of the 40-Gene Expression Profile (40-GEP) Test in Cutaneous Squamous Cell Carcinoma: Systematic Review and Meta-Analysis;Cancers;2023-04-25